|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1990-12-7
|
|
pubmed:abstractText |
The authors present a case report of neuroleptic malignant syndrome (NMS) in a patient commencing treatment with fluoxetine alone who had previously been treated with several antipsychotic and antidepressant combinations. On reviewing the literature on the pathogenesis of NMS, the authors hypothesize a facilitative role of the neurotransmitter serotonin (5-HT) in conjunction with central dopaminergic blockade in the precipitation of NMS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0006-3223
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
518-21
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:2223920-Depressive Disorder,
pubmed-meshheading:2223920-Drug Therapy, Combination,
pubmed-meshheading:2223920-Fluoxetine,
pubmed-meshheading:2223920-Humans,
pubmed-meshheading:2223920-Male,
pubmed-meshheading:2223920-Middle Aged,
pubmed-meshheading:2223920-Neuroleptic Malignant Syndrome,
pubmed-meshheading:2223920-Neurologic Examination,
pubmed-meshheading:2223920-Psychotic Disorders,
pubmed-meshheading:2223920-Recurrence
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Fluoxetine and neuroleptic malignant syndrome.
|
|
pubmed:affiliation |
Department of Psychiatry, Toronto General Hospital, University of Toronto, Canada.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
